Immunotherapy and Liver Transplantation The Future or the Failure?

被引：4

作者：

Tabrizian, Parissa ^{[1
]}

Yu, Allen ^{[1
]}

Debnath, Neha ^{[1
]}

Myers, Bryan ^{[1
]}

Marron, Thomas ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, Liver Transplant & Hepatobiliary Surg, One Gustave L Levy, New York, NY 10029 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2024年 / 104卷 / 01期

关键词：

Liver transplantation; Hepatocellular carcinoma; Immunotherapy; Rejection; Outcomes; RESECTABLE HEPATOCELLULAR-CARCINOMA; ATEZOLIZUMAB PLUS BEVACIZUMAB; NEOADJUVANT THERAPY; OPEN-LABEL; PHASE-III; TRIAL; RISK; PEMBROLIZUMAB; NIVOLUMAB; ADJUVANT;

D O I：

10.1016/j.suc.2023.07.009

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

center dot The increasing demand for liver transplantation (LT) for hepatocellular carcinoma (HCC) has led to the continued efforts to expand LT indications.center dot Immunotherapy has revolutionized the treatment of advanced HCC over the past few years.center dot HCC and other solid tumors exploit evolutionary conserved inhibitory immune checkpoints to evade antitumor immune response by upregulating cognate ligands or receptors capable of inhibiting antitumor immunity.

引用

页码：163 / 182

页数：20

共 50 条

[21] Liver transplantation: update and future directions
Imagawa, DK
NEW DIRECTIONS FOR CELLULAR AND ORGAN TRANSPLANTATION, 2000, 1210 : 113 - 118
[22] Emerging Insights on Immunotherapy in Liver Cancer
Zhang, Ying
Zhang, Xiang
Kuang, Ming
Yu, Jun
ANTIOXIDANTS & REDOX SIGNALING, 2022, 37 (16) : 1325 - 1338
[23] Challenges and future developments in liver transplantation
Toniutto, Pierluigi
Bitetto, Davide
Fornasiere, Ezio
Fumolo, Elisa
MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2019, 65 (02) : 136 - 152
[24] Timing and benefit of liver transplantation in acute liver failure
O'Grady, John
JOURNAL OF HEPATOLOGY, 2014, 60 (03) : 663 - 670
[25] Assessment of adult patients with chronic liver failure for liver transplantation in 2015: who and when?
McCaughan, G. W.
Crawford, M.
Sandroussi, C.
Koorey, D. J.
Bowen, D. G.
Shackel, N. A.
Strasser, S. I.
INTERNAL MEDICINE JOURNAL, 2016, 46 (04) : 404 - 412
[26] European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
Claasen, Marco Petrus Adrianus Wilhelmus
Sneiders, Dimitri
Rakke, Yannick Sebastiaan
Adam, Rene
Bhoori, Sherrie
Cillo, Umberto
Fondevila, Constantino
Reig, Maria
Sapisochin, Gonzalo
Tabrizian, Parissa
Toso, Christian
TRANSPLANT INTERNATIONAL, 2023, 36
[27] Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
Maggio, Ilaria
Manuzzi, Lisa
Lamberti, Giuseppe
Ricci, Angela Dalia
Tober, Nastassja
Campana, Davide
CANCERS, 2020, 12 (04)
[28] Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
He, Yuqing
Lu, Mengyao
Che, Jing
Chu, Qian
Zhang, Peng
Chen, Yuan
FRONTIERS IN ONCOLOGY, 2021, 11
[29] Immunotherapy in melanoma: Recent advances and future directions
Franklin, C.
Livingstone, E.
Roesch, A.
Schilling, B.
Schadendorf, D.
EJSO, 2017, 43 (03): : 604 - 611
[30] The Future of Liver Transplantation
O'Mahony, Christine A.
Goss, John A.
TEXAS HEART INSTITUTE JOURNAL, 2012, 39 (06) : 874 - 875

← 1 2 3 4 5 →